BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

597 related articles for article (PubMed ID: 12423680)

  • 21. Hypoxia-simulating agents and selective stimulation of arsenic trioxide-induced growth arrest and cell differentiation in acute promyelocytic leukemic cells.
    Yan H; Peng ZG; Wu YL; Jiang Y; Yu Y; Huang Y; Zhu YS; Zhao Q; Chen GQ
    Haematologica; 2005 Dec; 90(12):1607-16. PubMed ID: 16330433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TRAIL decoy receptors mediate resistance of acute myeloid leukemia cells to TRAIL.
    Riccioni R; Pasquini L; Mariani G; Saulle E; Rossini A; Diverio D; Pelosi E; Vitale A; Chierichini A; Cedrone M; Foà R; Lo Coco F; Peschle C; Testa U
    Haematologica; 2005 May; 90(5):612-24. PubMed ID: 15921376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arsenic trioxide (As2O3)-induced apoptosis and differentiation in retinoic acid-resistant acute promyelocytic leukemia model in hGM-CSF-producing transgenic SCID mice.
    Kinjo K; Kizaki M; Muto A; Fukuchi Y; Umezawa A; Yamato K; Nishihara T; Hata J; Ito M; Ueyama Y; Ikeda Y
    Leukemia; 2000 Mar; 14(3):431-8. PubMed ID: 10720138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.
    Ahn MJ; Nason-Burchenal K; Moasser MM; Dmitrovsky E
    Oncogene; 1995 Jun; 10(12):2307-14. PubMed ID: 7784078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishment and characterization of a novel acute promyelocytic leukemia cell line (UF-1) with retinoic acid-resistant features.
    Kizaki M; Matsushita H; Takayama N; Muto A; Ueno H; Awaya N; Kawai Y; Asou H; Kamada N; Ikeda Y
    Blood; 1996 Sep; 88(5):1824-33. PubMed ID: 8781440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of retinoid resistance in leukemic cells: possible role of cytochrome P450 and P-glycoprotein.
    Kizaki M; Ueno H; Yamazoe Y; Shimada M; Takayama N; Muto A; Matsushita H; Nakajima H; Morikawa M; Koeffler HP; Ikeda Y
    Blood; 1996 Jan; 87(2):725-33. PubMed ID: 8555497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leukemic cellular retinoic acid resistance and missense mutations in the PML-RARalpha fusion gene after relapse of acute promyelocytic leukemia from treatment with all-trans retinoic acid and intensive chemotherapy.
    Ding W; Li YP; Nobile LM; Grills G; Carrera I; Paietta E; Tallman MS; Wiernik PH; Gallagher RE
    Blood; 1998 Aug; 92(4):1172-83. PubMed ID: 9694705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of growth sensitivity of acute promyelocytic leukemia cells to granulocyte colony-stimulating factor using 7AAD/PY during administration of all-trans retinoic acid.
    Toba K; Koike T; Wang Y; Nagai K; Takahashi H; Hashimoto S; Uesugi Y; Aizawa Y
    Int J Hematol; 1997 Aug; 66(2):203-12. PubMed ID: 9277051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FOXO3A as a key molecule for all-trans retinoic acid-induced granulocytic differentiation and apoptosis in acute promyelocytic leukemia.
    Sakoe Y; Sakoe K; Kirito K; Ozawa K; Komatsu N
    Blood; 2010 May; 115(18):3787-95. PubMed ID: 20215638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. all-trans-Retinoic acid-induced expression and regulation of retinoic acid 4-hydroxylase (CYP26) in human promyelocytic leukemia.
    Ozpolat B; Mehta K; Tari AM; Lopez-Berestein G
    Am J Hematol; 2002 May; 70(1):39-47. PubMed ID: 11994980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of autophagy is a key component of all-trans-retinoic acid-induced differentiation in leukemia cells and a potential target for pharmacologic modulation.
    Orfali N; O'Donovan TR; Nyhan MJ; Britschgi A; Tschan MP; Cahill MR; Mongan NP; Gudas LJ; McKenna SL
    Exp Hematol; 2015 Sep; 43(9):781-93.e2. PubMed ID: 25986473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel retinoic acid, 9-cis retinoic acid, in combination with all-trans retinoic acid is an effective inducer of differentiation of retinoic acid-resistant HL-60 cells.
    Kizaki M; Nakajima H; Mori S; Koike T; Morikawa M; Ohta M; Saito M; Koeffler HP; Ikeda Y
    Blood; 1994 Jun; 83(11):3289-97. PubMed ID: 8193364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Understanding the molecular pathogenesis of acute promyelocytic leukemia.
    Lo-Coco F; Hasan SK
    Best Pract Res Clin Haematol; 2014 Mar; 27(1):3-9. PubMed ID: 24907012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Src family kinase inhibitor PP2 enhances differentiation of acute promyelocytic leukemia cell line induced by combination of all-trans-retinoic acid and arsenic trioxide.
    Jung YS; Cheong HJ; Kim SJ; Kim KH; Lee N; Park HS; Won JH
    Leuk Res; 2014 Aug; 38(8):977-82. PubMed ID: 24953245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cotylenin A--a plant growth regulator as a differentiation-inducing agent against myeloid leukemia.
    Honma Y
    Leuk Lymphoma; 2002 Jun; 43(6):1169-78. PubMed ID: 12152984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of all-trans retinoic acid and arsenic trioxide on tissue factor expression in acute promyelocytic leukemia cells.
    Guo W; Wang H; Zhao W; Zhu J; Ju B; Wang X
    Chin Med J (Engl); 2001 Jan; 114(1):30-4. PubMed ID: 11779431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retinoid induced apoptosis in leukemia cells through a retinoic acid nuclear receptor-independent pathway.
    Hsu CA; Rishi AK; Su-Li X; Gerald TM; Dawson MI; Schiffer C; Reichert U; Shroot B; Poirier GG; Fontana JA
    Blood; 1997 Jun; 89(12):4470-9. PubMed ID: 9192771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Establishment of a human acute promyelocytic leukemia-ascites model in SCID mice.
    Zhang SY; Zhu J; Chen GQ; Du XX; Lu LJ; Zhang Z; Zhong HJ; Chen HR; Wang ZY; Berger R; Lanotte M; Waxman S; Chen Z; Chen SJ
    Blood; 1996 Apr; 87(8):3404-9. PubMed ID: 8605358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arsenic trioxide therapy for relapsed acute promyelocytic leukemia: an useful salvage therapy.
    Huan SY; Yang CH; Chen YC
    Leuk Lymphoma; 2000 Jul; 38(3-4):283-93. PubMed ID: 10830735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Restoration of CCAAT enhancer binding protein α P42 induces myeloid differentiation and overcomes all-trans retinoic acid resistance in human acute promyelocytic leukemia NB4-R1 cells.
    Wang L; Xiao H; Zhang X; Liao W; Fu S; Huang H
    Int J Oncol; 2015 Nov; 47(5):1685-95. PubMed ID: 26397153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.